Nosebleed in Midol - how severe and when it was recovered? (a real world drug study)
Summary:
We study how severe was Nosebleed, when it was recovered, drug effectiveness, race, and more among people who take Midol (ibuprofen). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.
What is Midol?
Midol has active ingredients of ibuprofen. It is often used in painful menstrual periods. eHealthMe is studying from 2,635 Midol users. Check the latest studies of Midol.
What is Nosebleed?
Nosebleed (bleeding from nose) is found to be associated with 2,082 drugs and 3,091 conditions by eHealthMe. Check the latest studies of Nosebleed.
11 people who have Nosebleed while taking Midol were studied.

Severity of Nosebleed *:
- least: 37.5 %
- moderate: 50.0 %
- severe: 12.5 %
- most severe: 0.0 %
When people recovered from Nosebleed *:
- while on drug: 0.0 %
- after off the drug: 0.0 %
- not yet: 100 %
Effectiveness of Midol *:
- not at all: 0.0 %
- somewhat: 16.67 %
- moderate: 50.0 %
- high: 33.33 %
- very high: 0.0 %
Race of the people *:
- African American, Non-Hispanic: 0.0 %
- American Indian/Alaska Native: 0.0 %
- Asian: 0.0 %
- Hispanic: 12.5 %
- Native Hawaiians/Pacific Islanders: 0.0 %
- Two or more races: 25.0 %
- White, Non-Hispanic: 62.5 %
Time on Midol *:
- < 1 month: 14.29 %
- 1 - 6 months: 14.29 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 28.57 %
- 5 - 10 years: 14.29 %
- 10+ years: 28.57 %
Gender of people when taking Midol *:
- female: 72.73 %
- male: 27.27 %
Age of people when taking Midol *:
- 0-1: 0.0 %
- 2-9: 9.09 %
- 10-19: 0.0 %
- 20-29: 27.27 %
- 30-39: 0.0 %
- 40-49: 18.18 %
- 50-59: 9.09 %
- 60+: 36.36 %
Conditions people have *:
- Pain: 3 people, 27.27%
- Headache (pain in head): 2 people, 18.18%
- Toothaches (tooth pain): 1 person, 9.09%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 9.09%
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 9.09%
- Bipolar Disorder (mood disorder): 1 person, 9.09%
- Cholesterosis (abnormal deposition of cholesterol in tissues): 1 person, 9.09%
- Earache (ear pain): 1 person, 9.09%
- Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 9.09%
Other drugs people take besides Midol *:
- Zyrtec: 1 person, 9.09%
- Zebeta: 1 person, 9.09%
- Alprazolam: 1 person, 9.09%
- Ambien: 1 person, 9.09%
- Amoxicillin: 1 person, 9.09%
- Augmentin '875': 1 person, 9.09%
- Bactrim: 1 person, 9.09%
- Diclofenac: 1 person, 9.09%
- Flonase: 1 person, 9.09%
- Gabapentin: 1 person, 9.09%
Other side effects people have besides Nosebleed *:
- Weight Loss: 1 person, 9.09%
- Vaginal Bleeding Between Periods: 1 person, 9.09%
- Back Pain - Low: 1 person, 9.09%
- Bipolar Disorder (mood disorder): 1 person, 9.09%
- Chest Pain: 1 person, 9.09%
- Cough: 1 person, 9.09%
- Cough Aggravated: 1 person, 9.09%
- Fever: 1 person, 9.09%
- Flank Pain (a distressing sensation experienced around the lower back and the upper abdomen): 1 person, 9.09%
- Frequent Or Urgent Urination: 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Midol and have Nosebleed?
Check whether Nosebleed is associated with a drug or a conditionHow to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
How the study uses the data?
The study is based on ibuprofen (the active ingredients of Midol). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Allopurinol and Seizure Control for Boys aged 10-19 - 3 seconds ago
- Allopurinol and Seizure for Boys aged 10-19 - 3 seconds ago
- Allopurinol and Seizures for Boys aged 10-19 - 4 seconds ago
- Serotonin Syndrome and drugs of ingredients of acetaminophen; oxycodone hydrochloride - 9 seconds ago
- Could Magnesium Citrate cause Burning Sensation? - 10 seconds ago
- Alli vs. Vivitrol, side effect and effectiveness comparison - 28 seconds ago
- Opsumit and Zosyn drug interactions for women aged 50-59 - 39 seconds ago
- Zocor and Diabetic Ketoacidosis for Women aged 30-39 - 42 seconds ago
- Zocor and Ketoacidosis for Women aged 30-39 - 43 seconds ago
- Zocor and Dka for Women aged 30-39 - 43 seconds ago